Advertisement

August 3, 2020

Sirtex Medical Launches the Siros System for Delivery of SIR-Spheres in Liver Cancer Treatment

August 3, 2020—Sirtex Medical US Holdings, Inc. announced the launch of the Siros system for the delivery of the company’s SIR-Spheres yttrium-90 resin microspheres in the targeted treatment of liver cancer.

According to Sirtex, the Siros system’s visually controlled administration allows physicians to determine and adjust the precise quantity and speed of SIR-Spheres microspheres delivery. Additionally, the system is designed to be simple and versatile to allow expanded options for patient-tailored delivery. Siros features a peel-and-place tubing set; the company’s needleless D-Vial that suspends SIR-Spheres into a vortex that may allow for a more even distribution; and a locking cover that safely secures the microspheres during delivery.

Advertisement


August 3, 2020

Terumo Europe Initiates Postmarket PRIZER Study of the Renzan Stent System

August 2, 2020

Siemens Healthineers Plans to Acquire Varian for $16.4 Billion